Hyam I. Levitsky, MD, Joins Antigenics' Board of Directors.NEW YORK -- Antigenics Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on : AGEN) today announced the appointment of Hyam I. Levitsky, MD, to its board of directors. Currently a professor of oncology, medicine and urology at The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, the scientific director of Johns Hopkins' George Santos Bone Marrow Transplant bone marrow transplant: see bone marrow. Program, and a member of the Cancer Vaccine Consortium's executive council, Dr. Levitsky's appointment brings more than 15 years of clinical and research experience to Antigenics' board of directors. "Hy's research has formed the basis for the development of several novel immunotherapeutic agents for a variety of different cancers," said Garo H. Armen Garo H. Armen is chairman and chief executive officer of Antigenics Inc., the biotechnology company he cofounded with Pramod Srivastava in 1994. From mid-2002 through 2004, he was chairman of the board of directors for the biopharmaceutical company Elan Corporation plc. Dr. , PhD, chairman and CEO of Antigenics. "His addition brings a substantial level of relevant scientific and clinical expertise. We are delighted to have him on board as we focus on our four priority clinical-stage programs in the field of vaccines and cancer therapeutics." Dr. Levitsky's laboratory research involves basic studies of antigen processing and presentation, T-cell co-stimulation, T-cell priming versus tolerance, and the evolution of tumor-specific immunity during immune reconstitution. He has received numerous awards for his research, including the Stohlman Scholars Award from the Leukemia and Lymphoma Foundation of America, The Senior Research Award from the Multiple Myeloma Research Foundation, Research Awards from the CapCURE foundation, The American Cancer Society American Cancer Society, n.pr established in 1913, this national volunteer-based health organization is committed to the elimination of cancer through prevention and treatment and to diminishing cancer suffering through advocacy, scholarship, research, and the National Institutes of Health. In 2001, he was elected to the American Society for Clinical Investigation. Dr. Levitsky received his undergraduate degree in engineering from the University of Pennsylvania (body, education) University of Pennsylvania - The home of ENIAC and Machiavelli. http://upenn.edu/. Address: Philadelphia, PA, USA. in 1980, and his medical degree from the Johns Hopkins University School of Medicine The Johns Hopkins University School of Medicine, located in Baltimore, Maryland, USA, is a highly regarded medical school and biomedical research institute in the United States. in 1984. He did his internship and residency in internal medicine at Johns Hopkins Hospital
About Antigenics Antigenics (NASDAQ: AGEN) is working to develop treatments for cancers, infectious diseases and autoimmune disorders. The company's investigational product portfolio includes Oncophage(R) (vitespen), a patient-specific therapeutic cancer vaccine being evaluated in several indications; Aroplatin(TM), a liposomal, third-generation platinum chemotherapeutic; ATRA-IV, a liposomal retinoic acid; AG-707, a therapeutic vaccine for the treatment of genital herpes; AU-801, a preclinical program targeting autoimmune disorders; and QS-21, an adjuvant being evaluated by Antigenics' corporate partners in several late-stage clinical trials. For more information, please visit www.antigenics.com. Participation of Dr. Levitsky on Antigenics' board of directors does not constitute or imply endorsement by the Johns Hopkins University Johns Hopkins University, mainly at Baltimore, Md. Johns Hopkins in 1867 had a group of his associates incorporated as the trustees of a university and a hospital, endowing each with $3.5 million. Daniel C. or the Johns Hopkins University Hospital and Health System. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion